title: Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.
authors.affiliation: Division of Renal Diseases and Hypertension, Transplant Center, University of Colorado, Denver, Colorado Alexander.wiseman@ucdenver.edu.
authors.forename: Alexander C
authors.initials: AC
authors.lastname: Wiseman
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D065095:Calcineurin Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D009173:Mycophenolic Acid / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D013256:Steroids; D009173:Mycophenolic Acid; D016559:Tacrolimus
keywords: basiliximab; induction therapy; live donor; thymoglobulin; transplantation